| Overview |
| bs-6700R-PE-Cy5 |
| SRD5A2 (3-oxo-5-alpha-steroid 4-dehydrogenase 2) Polyclonal Antibody, PE-Cy5 Conjugated |
| WB |
| 83% sequence similarity with 3-oxo-5-alpha-steroid 4-dehydrogenase 1 (SRD5A1) |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human SRD5A2 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 6716 |
| 5 alpha SR2; EC; SR type 2; Steroid 5 alpha reductase 2; 3 oxo 5 alpha steroid 4 dehydrogenase 2; 3-oxo-5-alpha-steroid 4-dehydrogenase 2; 5 alpha-SR2; 5ART2; e II 5 alpha reductase; EC; MGC138457; Micropenis, included; S5A2_HUMAN; S5AR 2; SR type 2; SRD5A2; Steroid 5 alpha reductase 2; Steroid 5-alpha-reductase 2; Steroid-5-alpha-reductase, alpha polypeptide 2 3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2; Type II 5-alpha reductase. |
| Converts testosterone (T) into 5-alpha-dihydrotestosterone (DHT) and progesterone or corticosterone into their corresponding 5-alpha-3-oxosteroids. It plays a central role in sexual differentiation and androgen physiology. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz